Behrang Kianzad is a LLM / PhD-Fellow in EU Intellectual Property and EU Competition Law at the University of Copenhagen, Faculty of Law. He also lectures Health & Life Science Law and is a Legal consultant in Pharma Competition & Access. His areas of work include IP, IT, Law & Economics & comparative law. His main research topics deal with the intersection of Intellectual Property and Competition Law, specifically in regards to pharmaceutical markets and excessive pricing. He has presented his research and held expert meetings at WHO, MSF, WTO/WIPO IP Researchers Meeting, World Intellectual Property Forum and numerous law and economic conferences around Europe. His publications are found at Springer, Oxford University Press and some of the leading Competition Law and IP Law journals. He is also a peer reviewer for European Journal of Law and Economics and contributing author to Encyclopedia of Law and Economics. He has 15+ years experience as an editor, manager & consultant in media, online advertising, PR, event & music management.
5039
L’interdiction des prix excessifs remonte à l’époque du roi babylonien Hammurabi. Pour beaucoup, cette interdiction est considérée comme controversée, allant à l’encontre de l’économie dominante et devrait être appliquée avec parcimonie. Le nombre réel de cas concernant des prix excessifs (...)
3547
La crise COVID-19 a fait ressortir de nombreux cas de hausses de prix spectaculaires de produits essentiels tels que les masques, les nettoyants pour les mains et les désinfectants. Afin d’avoir une vue d’ensemble de ces pratiques dans l’UE et des réponses ultérieures au droit de la (...)
Global Dictionary of Competition Law
